Skip to content

Members' voluntary liquidation OOSTERHOUT PHARMA-BIOTECH CONSULTING LTD

Enfield12215627-mvlDate: 07/05/2021Updated 03/10/2026, 03:40
More details available to registered users
Free access to practitioner details, reports and alerts

OOSTERHOUT PHARMA-BIOTECH CONSULTING LTD in Enfield (East of England) entered members' voluntary liquidation, a solvent winding-up. Engin Faik has been appointed as insolvency practitioner. The case reference is 12215627-mvl. The principal activity of OOSTERHOUT PHARMA-BIOTECH CONSULTING LTD is other professional, scientific and technical activities n.e.c..

General information

NameOOSTERHOUT PHARMA-BIOTECH CONSULTING LTD
TownEnfield (East of England)
Company number12215627
Case no.12215627-mvl
StatusMembers' voluntary liquidation
Order date07/05/2021
Company typePrivate limited company
Incorporated on19/09/2019
Company statusdissolved
Dissolved on14/04/2022

Sector

GroupProfessional, scientific and technical activities
Primary codeOther professional, scientific and technical activities n.e.c. (74909)

Offices and addresses

Registered office
136 Hertford Road
EN3 5AX Enfield

Directors

Directors are visible after free registrationRegister free

Notices

07/05/2021Resolution
3797028
07/05/2021CompanyIssuedNotice
3797027
07/05/2021CompanyIssuedLiquidatorAppointment
3797026

Insolvency practitioner

Engin Faik
Address136 Hertford Road, EN3 5AX Enfield
Practitioner contact details are visible after free registrationRegister free

InsolvencyIndex draws on public sources and makes every effort to keep the content of this page up to date and complete. Despite that care, the content may be incomplete or inaccurate. InsolvencyIndex provides the content of this website "as is", without any warranty as to its soundness, fitness for a particular purpose or otherwise. InsolvencyIndex accepts no liability for loss arising from, or in any way connected with, the use of this website or any inability to consult it. Save as set out in this disclaimer, InsolvencyIndex is not responsible for third-party files linked from this page; linking does not imply any endorsement of those files. Notices reproduced here are extracts from official publications; if you believe an entry is inaccurate, please contact us and we will correct it.